Paul Nyirjesy
#149,427
Most Influential Person Now
American medical researcher
Paul Nyirjesy's AcademicInfluence.com Rankings
Paul Nyirjesyphilosophy Degrees
Philosophy
#11661
World Rank
#16100
Historical Rank
Logic
#8466
World Rank
#10603
Historical Rank
Paul Nyirjesybiology Degrees
Biology
#15413
World Rank
#19386
Historical Rank
Microbiology
#1033
World Rank
#1153
Historical Rank
Download Badge
Philosophy Biology
Paul Nyirjesy's Degrees
- Doctorate Medicine University of Pittsburgh
- PhD Microbiology University of Pittsburgh
Why Is Paul Nyirjesy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Paul Nyirjesy is a professor in the Department of Obstetrics and Gynecology at Drexel University, Philadelphia, and the director of Drexel Vaginitis Center. In 2016, Nyirjesy announced positive results from a clinical trial for a potential vaccine against Vaginitis.
Paul Nyirjesy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. (1998) (645)
- Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. (2006) (241)
- Over‐the‐Counter Antifungal Drug Misuse Associated With Patient‐Diagnosed Vulvovaginal Candidiasis (2002) (179)
- Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. (2001) (149)
- Chronic fungal vaginitis: the value of cultures. (1995) (144)
- Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor (2012) (137)
- Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: a pooled analysis of clinical studies (2014) (135)
- Fluconazole Susceptibility of Vaginal Isolates Obtained from Women with Complicated Candida Vaginitis: Clinical Implications (2003) (130)
- Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. (2001) (127)
- A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections. (2015) (116)
- Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes (2019) (109)
- Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study (2001) (107)
- A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis—A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial (2018) (97)
- Vulvovaginal candidiasis and bacterial vaginosis. (2008) (96)
- Urinary Tract Infections in Women With Bacterial Vaginosis (2000) (93)
- Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: results of a prospective cohort study. (2004) (90)
- Metronidazole-resistant vaginal trichomoniasis--an emerging problem. (1999) (85)
- Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis. (1993) (82)
- Over‐the‐Counter and Alternative Medicines in the Treatment of Chronic Vaginal Symptoms (1997) (81)
- Causes of Chronic Vaginitis: Analysis of a Prospective Database of Affected Women (2006) (81)
- Genital Mycotic Infections in Patients With Diabetes (2013) (69)
- Difficult-to-treat trichomoniasis: results with paromomycin cream. (1998) (64)
- Endometrial ablation devices: review of a manufacturer and user facility device experience database. (2007) (58)
- Diagnostic Performance of a Molecular Test versus Clinician Assessment of Vaginitis (2018) (57)
- Clinical Validation of a Test for the Diagnosis of Vaginitis. (2017) (54)
- Chronic vulvovaginal candidiasis. (2001) (54)
- Management of persistent vaginitis. (2014) (54)
- A phase 2, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of orally administered VT‐1161 in the treatment of recurrent vulvovaginal candidiasis (2018) (50)
- Vaginal Candida parapsilosis: pathogen or bystander? (2005) (49)
- Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis: A Randomized Controlled Trial (2007) (49)
- Intravesical Foreign Body and Vesicovaginal Fistula: A Rare Complication of a Neglected Pessary (1999) (46)
- Role of Mycoplasma and Ureaplasma Species in Female Lower Genital Tract Infections (2010) (46)
- Recurrent vulvovaginitis. (2014) (44)
- The Interrelationship Between Ethnicity and Gestational Diabetes in Fetal Macrosomia (1995) (44)
- HIV type 1 cervicovaginal reservoirs in the era of HAART. (2005) (42)
- A phase‐3, double‐blind, placebo‐controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis (2017) (38)
- Saccharomyces cerevisiae Vaginitis: Transmission From Yeast Used in Baking (1995) (36)
- Resistant trichomoniasis: successful treatment with combination therapy. (2011) (35)
- Paromomycin for nitroimidazole-resistant trichomonosis (1995) (32)
- Variation in microbiologic profiles among pregnant women with bacterial vaginosis. (2005) (31)
- Topical Amitriptyline-Baclofen Cream for the Treatment of Provoked Vestibulodynia (2009) (30)
- Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study (2019) (28)
- The Effects of Intravaginal Clindamycin and Metronidazole Therapy on Vaginal Mobiluncus Morphotypes in Patients With Bacterial Vaginosis (2007) (26)
- A Randomized Phase 2 Study of VT-1161 for the Treatment of Acute Vulvovaginal Candidiasis (2020) (25)
- Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis. (2000) (25)
- Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. (2017) (24)
- Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole (2002) (24)
- Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment. (2018) (23)
- The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis. (2006) (23)
- Variation in vaginal immune parameters and microbial hydrolytic enzymes in bacterial vaginosis positive pregnant women with and without Mobiluncus species. (2006) (23)
- Management of Resistant Trichomoniasis (2019) (22)
- Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303) (2021) (22)
- Chronic Vulvovaginitis in Women Older Than 50 Years: Analysis of a Prospective Database (2012) (21)
- Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. (2021) (21)
- Nongonococcal and nonchlamydial cervicitis (2001) (21)
- Chronic Cervicitis: Presenting Features and Response to Therapy (2016) (20)
- Genitourinary manifestations of Epstein-Barr virus infections (2009) (20)
- Treatment of Recurrent Bacterial Vaginosis With Tinidazole (2004) (20)
- Non-albicans Candida Vulvovaginitis: Treatment Experience at a Tertiary Care Vaginitis Center (2016) (19)
- Candida glabrata complicating in vitro pregnancy: successful management of subsequent pregnancy. (2011) (18)
- Vaginitis in the adolescent patient. (1999) (18)
- Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study (2015) (18)
- ORIGINAL ARTICLE: Evaluation of Semen Detection in Vaginal Secretions: Comparison of Four Methods (2008) (18)
- Hyaluronan in vaginal secretions: association with recurrent vulvovaginal candidiasis. (2009) (17)
- Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers (2017) (17)
- Medical Management of Vulvar Vestibulitis: Results of a Sequential Treatment Plan (1995) (16)
- advances in diagnosing vaginitis: Development of a new algorithm (2005) (16)
- Paraurethral fascial sling urethropexy and vaginal paravaginal defects cystopexy in the correction of urethrovesical prolapse (1995) (15)
- Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo‐controlled superiority study (VANISH 306) (2021) (15)
- Creation of neovagina by laparoscopic Vecchietti operation. (1999) (14)
- Postmenopausal vaginitis (2007) (14)
- CD101 Topical Compared With Oral Fluconazole for Acute Vulvovaginal Candidiasis: A Randomized Controlled Trial. (2019) (14)
- Effect of gabapentin on sexual function in vulvodynia: a randomized, placebo‐controlled trial (2019) (14)
- Specific association of repetitive DNA sequences with major histocompatibility genes (1983) (14)
- Gluteal necrotizing myofascitis: an unusual delayed complication of abdominal sacrocolpopexy. (2001) (14)
- Over-the-Counter and Alternative Medicines in the Treatment of Chronic Vaginal Symptoms (1998) (14)
- Alternative Therapies in Women With Chronic Vaginitis (2011) (14)
- Vaginal Toxic Shock Reaction Triggering Desquamative Inflammatory Vaginitis (2013) (13)
- Vulvar vestibulitis syndrome: A post-infectious entity? (2000) (12)
- Fractionated CO2 Laser as Therapy in Recalcitrant Lichen Sclerosus (2020) (12)
- Metronidazole-Resistant Trichomoniasis: Beneficial Pharmacodynamic Relationship With High-Dose Oral Tinidazole and Vaginal Paromomycin Combination Therapy. (2019) (12)
- Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects (2011) (11)
- Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy (2018) (11)
- Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study (2021) (10)
- Use of the VS-sense swab in diagnosing vulvovaginitis. (2009) (10)
- Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis (2021) (9)
- Physician Awareness and Adherence to Clinical Practice Guidelines in the Diagnosis of Vaginitis Patients: A Retrospective Chart Review (2020) (9)
- New Perspectives on the Normal Vagina and Noninfectious Causes of Discharge (2015) (8)
- Managing resistant Trichomonas vaginitis (1999) (8)
- Impermeant potential-sensitive oxonol dyes: I. Evidence for an “On-off” mechanism (1988) (8)
- Streptococcal toxic shock-like syndrome as an unusual complication of laparoscopic tubal ligation. A case report. (1994) (8)
- MALASSEZIA FURFUR FOLLICULITIS OF THE VULVA: OLIVE OIL SOLVES THE MYSTERY (1994) (8)
- Vaginal birth after cesarean section in rural Zaire. Changing concepts. (1992) (7)
- P248 Sensitivity of the amsel’s criteria compared to the nugent score in absence and in presence of trichomonas vaginalis (TV) and/or candida SPP among women with symptomatic vaginitis/vaginosis (2015) (7)
- Impermeant potential-sensitive oxonol dyes: III. The dependence of the absorption signal on membrane potential (1988) (7)
- Understanding the EMR error control practices among gynecologic physicians (2013) (7)
- Trichomonas vaginalis Infection in a Tertiary Care Vaginitis Center (2015) (7)
- Genital Malodor in Women: A Modern Reappraisal (2012) (6)
- Results from a phase 2, randomized, double‐blind, placebo‐controlled, dose ranging study to evaluate the efficacy and safety of VT 1161 oral tablets in the treatment of patients with recurrent vulvovaginal candidiasis: 4 (2017) (6)
- Hysteroscopic Tubal Occlusion: Sterilization After Failed Laparoscopic or Abdominal Approaches (2008) (6)
- Re: A systematic review of drug treatment of vulvodynia: evidence of a strong placebo effect (2018) (5)
- Lichen sclerosus and other conditions mimicking vulvovaginal candidiasis (2002) (5)
- A Phase 2b, Dose-Finding Study Evaluating Oral Ibrexafungerp vs Fluconazole in Vulvovaginal Candidiasis (DOVE) [24J] (2019) (5)
- Congenital malaria in twins. (1995) (5)
- Vaginorectal Streptococcus porcinus in Pregnancy: An Emerging Pathogen? (2013) (4)
- Cytolytic Vaginosis: a Critical Appraisal of a Controversial Condition (2020) (4)
- 18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis (2016) (3)
- Neonatal care in northeast Zaire. (1991) (3)
- Comment on "Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition". (2015) (3)
- Significance of Genital Mycoplasmas in Pelvic Inflammatory Disease: Innocent Bystander! (1996) (3)
- Perihepatic Adhesions: Another Look (1995) (3)
- 6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis (2015) (3)
- 15: To evaluate the efficacy and safety of VT-1161, a potent, highly selective inhibitor of fungal CYP51, in treating women with a documented history of recurrent vulvovaginal candidiasis (RVVC) (2016) (3)
- Trospectomycin in Acute Pelvic Inflammatory Disease: A Preliminary Report (1997) (3)
- Impermeant potential-sensitive oxonol dyes: II. The dependence of the absorption signal on the length of alkyl substituents attached to the dye (1988) (2)
- Incarcerated Fibroid Uterus: A Rare Cause of Acute Abdominal Pain in a Nonpregnant Patient (1994) (1)
- 17: Efficacy and safety of oral VT-11611 in a randomized phase 2a study in patients with acute vulvovaginal candidiasis: six-month follow-up (2015) (1)
- 28: Chronic cervicitis: presenting features and responses to therapy (2015) (1)
- Results from RADIANT, a phase 2, randomized, open‐label, sponsor‐blinded study of CD101 topical in patients with moderate‐to‐severe acute vulvovaginal candidiasis: 5 (2017) (1)
- A post hoc analysis of secnidazole 2 g for the treatment of bacterial vaginosis: effect of 2016 FDA guidance on clinical response rates in a subpopulation of patients: 15 (2017) (1)
- Fulminant Tuberculosis Complicating Pregnancy in a Patient Infected with the Human Immunodeficiency Virus (1993) (1)
- Superficial Dyspareunia and Vulvar Vestibulitis (2009) (1)
- Vulvovaginitis (2020) (1)
- Trichomoniasis and the 2015 CDC STD Treatment Guidelines : New Insights , New Urgency (2016) (1)
- Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis 1 1 Special thanks to Betsy Foxman, PhD, for trial design guidance and manuscript review. Saundra Turner, FNP, PhD, and Lisa Woodward, RN, provided clinical trial support. (2002) (1)
- 54 – Infections of the Female Pelvis, Including Septic Abortion (2017) (1)
- Sequence of Pelvic Examination Does Not Affect Patients With Baseline Vulvovaginal Syndromes: A Randomized Clinical Trial (2020) (0)
- Efficacy and Safety of Oral Ibrexafungerp in Subjects with Vulvovaginal Candidiasis: Pooled Data from Two Phase 3, Randomized, Blinded, Study vs. Placebo (VANISH-303 and VANISH-306) (2022) (0)
- Iliopsoas Abscess: An Unexpected Sequela of Dilation and Evacuation (2014) (0)
- A phase 3, multi-center, prospective, randomized, placebo-controlled, delayed treatment, double-blind study to evaluate the effectiveness and safety of a single oral dose of 2 grams of secnidazole for the treatment of trichomoniasis in women (2020) (0)
- Long term outcomes of women with recurrent vulvovaginal candidiasis after a course of maintenance fluconazole: 26 (2017) (0)
- AbstractClinical science research poster presentationPredictors for Use of Alternative Therapies in Patients with Chronic Vaginal Symptoms: Analysis of a Prospective Database of Affected Women (2012) (0)
- Vaginal discharge (2020) (0)
- Propelled Lavage in the Reduction of Postoperative Infection in Vaginal Reconstructive Surgery (1994) (0)
- Specific Association ofRepetitive DNA Sequences withMajor Histocompatibili ty Genes (1983) (0)
- Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. (2022) (0)
- The performance of an innovative self-sampling test for vaginitis - Selfcare Journal (2017) (0)
- Vulvar vestibulitis (1991) (0)
- Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306 (2022) (0)
- Chronic Endometritis and Positive Mycoplasma Cultures: Is There a Correlation? (1995) (0)
- Chapter 50 – Infections of the female pelvis including septic abortion (2010) (0)
- 17: Comparative analysis of ESwab™ and standard collection systems for nugent scoring in the diagnosis of bacterial vaginosis (2015) (0)
- Effect of 2016 FDA guidance on study population and clinical response rates in patients with bacterial vaginosis: a phase 3 post hoc analysis (2019) (0)
- A Clinical Update In Treatment of Bacterial Vaginosis (2004) (0)
- Fluconazole-Resistant Candida Albicans Vaginal Infections at a Referral Center and Treated With Boric Acid. (2023) (0)
- Diagnosis of Vaginitis: New Thinking for a New Era. (2021) (0)
- Metronidazole‐resistant trichomoniasis: beneficial pharmacodynamic relationship with high‐dose oral tinidazole and vaginal paromomycin combination therapy: 3 (2018) (0)
- Emerging challenges in bacterial vaginosis (2000) (0)
This paper list is powered by the following services:
Other Resources About Paul Nyirjesy
What Schools Are Affiliated With Paul Nyirjesy?
Paul Nyirjesy is affiliated with the following schools:
